Federal contract award
75F40123F19096
TO OBTAIN A SCIENTIFIC ADMIN II SUPPORT SPECIALIST TO SUPPORT THE RESEARCH PROGRAM OF THE FDA?S CENTER FOR BIOLOGICS EVALUATION AND RESEARCH, OFFICE OF THERAPEUTIC PRODUCTS (OPT), GENE TRANSFER AND IMMUNOGENICITY BRANCH (GTIB).
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | FDA OFFICE OF ACQ GRANT SVCS |
| NAICS | 541690 — Other Scientific and Technical Consulting Services |
| PSC | R499 — Other Professional Services |
| Parent award / vehicle | 75F40119D10015 |
| Set-aside | Not reported |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $141.3K |
| Current contract value | $141.3K |
| Potential contract value / ceiling | $141.3K |
| Start date | Aug 16, 2023 |
| Current end date | Sep 15, 2025 |
| Potential end date | Sep 15, 2025 |
| Latest award activity | Jun 11, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 4 of 4 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Jun 11, 2026 | P00003 | $-122.6K | TO OBTAIN A SCIENTIFIC ADMIN II SUPPORT SPECIALIST TO SUPPORT THE RESEARCH PROGRAM OF THE FDAS CENTER FOR BIOLOGICS EVALUATION AND RESEARCH, OFFICE OF THERAPEUTIC PRODUCTS (OPT), GENE TRANSFER AND IMMUNOGENICITY BRANCH (GTIB). |
| Apr 1, 2025 | P00002 | $0 | EOI::DEFEND THE SPEND::EOI TERMINATION FOR CONVENIENCE AGREEMENT |
| Jun 18, 2024 | P00001 | $132.0K | TO OBTAIN A SCIENTIFIC ADMIN II SUPPORT SPECIALIST TO SUPPORT THE RESEARCH PROGRAM OF THE FDA?S CENTER FOR BIOLOGICS EVALUATION AND RESEARCH, OFFICE OF THERAPEUTIC PRODUCTS (OPT), GENE TRANSFER AND IMMUNOGENICITY BRANCH (GTIB). |
| Aug 16, 2023 | 0 | $132.0K | TO OBTAIN A SCIENTIFIC ADMIN II SUPPORT SPECIALIST TO SUPPORT THE RESEARCH PROGRAM OF THE FDA?S CENTER FOR BIOLOGICS EVALUATION AND RESEARCH, OFFICE OF THERAPEUTIC PRODUCTS (OPT), GENE TRANSFER AND IMMUNOGENICITY BRANCH (GTIB). |
Research next steps
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.